Therapeutic Advances in Endocrinology and Metabolism

Papers
(The TQCC of Therapeutic Advances in Endocrinology and Metabolism is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Controversies in the management of active Charcot neuroarthropathy98
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study63
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults51
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review31
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity21
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review21
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers20
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease20
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis20
Update on genetics and epigenetics in metabolic associated fatty liver disease18
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system17
Pheochromocytoma: a changing perspective and current concepts16
Is there a causal relationship between hypothyroidism and hyponatremia?16
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor16
Retraction notice15
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study15
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus15
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication14
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective14
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis13
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes13
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bis13
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes13
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study13
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study13
Bone health in transgender people: a narrative review13
Thanks to Reviewers12
Gender-affirming endocrine care for youth with a nonbinary gender identity12
Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled c11
Analysis of vitamin D nutritional status and disease risk factors in patients with subacute thyroiditis10
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review10
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease9
Timing of osteoporosis therapies following fracture: the current status9
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study9
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease8
Qualitative evaluation of the symptoms and quality of life impacts of long-chain fatty acid oxidation disorders8
Implications of gender-affirming endocrine care for sports participation8
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions8
0.042762994766235